Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study

E Carluccio, FL Dini, R Bitto, M Ciccarelli… - International Journal of …, 2022 - Elsevier
Background Sacubitril/valsartan improves outcome in patients with heart failure (HF) with
reduced left ventricular (LV) ejection fraction (EF, HFrEF). However, little is known about …
被引用次数：17 相关文章

Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study

E Carluccio, FL Dini, R Bitto, M Ciccarelli… - INTERNATIONAL …, 2022 - iris.unibs.it
Background: Sacubitril/valsartan improves outcome in patients with heart failure (HF) with
reduced left ventricular (LV) ejection fraction (EF, HFrEF). However, little is known about …

Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study

E Carluccio, FL Dini, R Bitto… - International …, 2022 - internationaljournalofcardiology.com
Background Sacubitril/valsartan improves outcome in patients with heart failure (HF) with
reduced left ventricular (LV) ejection fraction (EF, HFrEF). However, little is known about …

Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study.

E Carluccio, FL Dini, R Bitto, M Ciccarelli… - … Journal of Cardiology, 2022 - europepmc.org
Background Sacubitril/valsartan improves outcome in patients with heart failure (HF) with
reduced left ventricular (LV) ejection fraction (EF, HFrEF). However, little is known about …

Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study

E Carluccio, FL Dini, R Bitto, M Ciccarelli… - INTERNATIONAL …, 2022 - fair.unifg.it
Background: Sacubitril/valsartan improves outcome in patients with heart failure (HF) with
reduced left ventricular (LV) ejection fraction (EF, HFrEF). However, little is known about …

Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study

E Carluccio, FL Dini, R Bitto, M Ciccarelli… - INTERNATIONAL …, 2022 - iris.unime.it
Background: Sacubitril/valsartan improves outcome in patients with heart failure (HF) with
reduced left ventricular (LV) ejection fraction (EF, HFrEF). However, little is known about …

Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study

E Carluccio, FL Dini, R Bitto, M Ciccarelli… - INTERNATIONAL …, 2022 - air.unimi.it
Background Sacubitril/valsartan improves outcome in patients with heart failure (HF) with
reduced left ventricular (LV) ejection fraction (EF, HFrEF). However, little is known about …

Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study

E Carluccio, FL Dini, R Bitto, M Ciccarelli… - INTERNATIONAL …, 2022 - iris.unisa.it
Background: Sacubitril/valsartan improves outcome in patients with heart failure (HF) with
reduced left ventricular (LV) ejection fraction (EF, HFrEF). However, little is known about …

Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study

E Carluccio, FL Dini, R Bitto… - International …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Sacubitril/valsartan improves outcome in patients with heart failure (HF) with
reduced left ventricular (LV) ejection fraction (EF, HFrEF). However, little is known about …

Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study

E Carluccio, LD Frank, R Bitto, M Ciccarelli… - INTERNATIONAL …, 2022 - research.unipg.it
Background: Sacubitril/valsartan improves outcome in patients with heart failure (HF) with
reduced left ventricular (LV) ejection fraction (EF, HFrEF). However, little is known about …